Treprostinil Stocks List
|UTHR||B||United Therapeutics Corporation||2.12|
|ASND||D||Ascendis Pharma A/S||3.88|
|LQDA||D||Liquidia Technologies, Inc.||-0.73|
|FTXH||C||First Trust Nasdaq Pharmaceuticals ETF||9.26|
|ZIG||A||The Acquirers Fund||3.73|
|PJP||C||PowerShares Dynamic Pharmaceuticals||3.65|
|PBE||C||PowerShares Dynamic Biotech & Genome||3.5|
|FBT||C||First Trust Amex Biotech Index Fund||3.23|
View all Treprostinil related ETFs...
Treprostinil (marketed under the trade names Remodulin for infusion, Orenitram for oral, and Tyvaso for inhalation) is a vasodilator that is used for the treatment of pulmonary arterial hypertension. Treprostinil is a synthetic analog of prostacyclin (PGI2).
The inhaled form of treprostinil was approved by the FDA in July 2009 and is marketed as the trade name Tyvaso.